Loading...

ImmunoGen, Inc.

IMU.DE•XETRA
Healthcare
Biotechnology
€5.17
€0.00(0.00%)

ImmunoGen, Inc. (IMU.DE) Stock Overview

Explore ImmunoGen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap1.1B
P/E Ratio-5.53
EPS (TTM)$-0.56
ROE-0.93%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$2.46

IMU.DE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ImmunoGen, Inc. (IMU.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.46.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.53 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;